# Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD)

> **NCT00817024** · NA · COMPLETED · sponsor: **Guang'anmen Hospital of China Academy of Chinese Medical Sciences** · enrollment: 90 (estimated)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DRUG:** Xuefu Zhuyu Capsules Plus Placebo of Sheng Mai Capsules,
- **DRUG:** Sheng Mai Capsules Plus Placebo of Xuefu Zhuyu Capsules
- **DRUG:** Placebo of Xuefu Zhuyu Capsules Plus Placebo of Sheng Mai Capsules

## Key facts

- **NCT ID:** NCT00817024
- **Lead sponsor:** Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2012-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00817024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00817024, "Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00817024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*